Anaphase Neoptide Serum
Efficacy and tolerability on the hair and scalp after hair transplantation

anaphase_neoptide_anti-hair-loss_anchorage-serum_50ml
Status
Status :
Completed
Type of study
Post-marketing study
Min. Age
26
Years old
Max. Age
64
Years old
Gender
Male

Brief summary

The objectives of this study were to evaluate the efficacy and tolerability of Anaphase Neoptide serum on the hair and scalp during the first 12 months after hair transplantation compared to a control group.

The subjects' scalp was evaluated during 9 dermatological consultations spread over 12 months.

Field of application :
Dermatology
Target :
Alopecia
Dermo-cosmetic product : ANAPHASE NEOPTIDE serum
Brand : Ducray
Start Date :
July 2021
End Date :
June 2023
Number of subjects :

30

Countries :
Spain
Study ID : RV4986A20200299